We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$6.87B
AUM Growth
+$918M
Cap. Flow
+$404M
Cap. Flow %
5.88%
Top 10 Hldgs %
30.67%
Holding
79
New
4
Increased
35
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$186M
2
AA icon
Alcoa
AA
+$148M
3
PPO
POLYPORE INTERNATIONAL, INC
PPO
+$130M
4
CTXS
Citrix Systems Inc
CTXS
+$104M
5
FTI icon
TechnipFMC
FTI
+$87.3M

Top Sells

Rank Stock Value
1
MOLXA
MOLEX INC CL-A
MOLXA
+$93.4M
2
MOLX
MOLEX INC
MOLX
+$90.6M
3
BSX icon
Boston Scientific
BSX
+$74M
4
BLC
BELO CORP SER A
BLC
+$57.9M
5
LUV icon
Southwest Airlines
LUV
+$50.2M

Sector Composition

Rank Sector Weight
1 Technology 29.22%
2 Industrials 16.12%
3 Healthcare 10.99%
4 Communication Services 9.03%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLB icon
51
Dolby
DLB
$4.97B
$30.8M 0.45%
799,100
+9,000
+1% +$324K
SF
52
Stifel
SF
$12.4B
$29.7M 0.43%
1,395,900
– –
CGG
53
DELISTED
CGG
CGG
$4.45M 0.06%
8,022
-4,983
-38% -$3.27M
FNSR
54
DELISTED
Finisar Corp
FNSR
$2.16M 0.03%
90,400
-16,800
-16% -$383K
SXT icon
55
Sensient Technologies
SXT
$5.22B
$1.49M 0.02%
30,730
-2,000
-6% -$99.6K
LM
56
DELISTED
Legg Mason, Inc.
LM
$1.33M 0.02%
30,700
+1,000
+3% +$38.8K
HPQ icon
57
HP
HPQ
$26B
$1.2M 0.02%
94,025
+4,183
+5% +$48K
CCL icon
58
Carnival Corporation Ltd
CCL
$38.1B
$1.06M 0.02%
26,450
+1,700
+7% +$60K
WOOF
59
DELISTED
VCA Inc.
WOOF
$988K 0.01%
31,500
+1,800
+6% +$52.5K
PEP icon
60
PepsiCo
PEP
$196B
$958K 0.01%
11,550
+800
+7% +$66.4K
UL icon
61
Unilever
UL
$142B
$882K 0.01%
19,022
+5,511
+41% +$247K
AVP
62
DELISTED
Avon Products, Inc.
AVP
$842K 0.01%
48,900
+9,900
+25% +$185K
APA icon
63
APA Corp
APA
$13B
$827K 0.01%
9,620
+800
+9% +$71.2K
QVCGA
64
DELISTED
QVC Group Inc Series A
QVCGA
$813K 0.01%
674
+29
+4% +$32.3K
TW
65
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$798K 0.01%
6,255
-2,700
-30% -$314K
CVE icon
66
Cenovus Energy
CVE
$54.2B
$785K 0.01%
27,400
+2,200
+9% +$64.1K
TFCFA
67
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$623K 0.01%
+17,700
New +$597K
HOLX
68
DELISTED
Hologic
HOLX
$387K 0.01%
+17,300
New +$381K
IBM icon
69
IBM
IBM
$213B
$308K ﹤0.01%
1,716
– –
JPM icon
70
JPMorgan Chase
JPM
$916B
$281K ﹤0.01%
4,799
-1,100
-19% -$60.3K
NVS icon
71
Novartis
NVS
$302B
$257K ﹤0.01%
3,571
– –
TU icon
72
Telus
TU
$17.4B
$248K ﹤0.01%
14,400
-600
-4% -$10.4K
DISCK
73
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$219K ﹤0.01%
5,220
– –
BLC
74
DELISTED
BELO CORP SER A
BLC
– –
-4,227,313
Closed -$57.9M
MOLX
75
DELISTED
MOLEX INC
MOLX
– –
-2,352,583
Closed -$90.6M
1 2
3
4

Similar funds

EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
CIA
CSat Investment Advisory Detroit, Michigan $119M AUM 77.51% 1-Year Est. Return
FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return

Fairpointe Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Fairpointe Capital held 79 positions worth $6.87B, up 15% from $5.95B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fairpointe Capital deployed $404M of net new capital in Q4 2013, opening 4 new positions and adding to 35 existing holdings. Its largest new stake was Alcoa: 6,662,124 shares worth $170M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Boston Scientific, an estimated $74M trimmed.

  • Fairpointe Capital's largest Q4 2013 buy was Alcoa: 6,662,124 shares worth $170M.
  • Fairpointe Capital added most to Edwards Lifesciences in Q4 2013, an estimated $186M increase.
  • Fairpointe Capital's biggest Q4 2013 reduction was Boston Scientific, cutting an estimated $74M.
  • Fairpointe Capital fully exited MOLEX INC CL-A in Q4 2013, selling an estimated $93.4M.
  • Fairpointe Capital's ten largest holdings make up 31% of its $6.87B portfolio in Q4 2013.
  • Fairpointe Capital opened 4 new positions and closed 3 in Q4 2013.
  • Fairpointe Capital's portfolio value rose 15% quarter-over-quarter to $6.87B.

Based on Fairpointe Capital's 13F filing for Q4 2013, filed 11 Feb 2014.